ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 255,01
0,58%
Dow Jones
44 296,51
0,97%
DAX
19 322,59
0,91%
Brent Oil
74,745
-0,03%
Bitcoin
97 572,00
-0,31%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Takeda Pharmaceutical Co Ltd (0RN3)

  7. Takeda Pharmaceutical Co Ltd (0RN3) Actualités

0RN3

Takeda Pharmaceutical (0RN3)

Takeda Pharmaceutical Co Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0RN3
DateHeureSourceTitreSymboleSociété
22/11/202411h00Alliance NewsAlliance NewsHutchmed to get payment from Takeda as Fruzaqla launched in JapanLSE:0RN3Takeda Pharmaceutical Co Ltd
31/10/202417h26Alliance NewsAlliance NewsTOP NEWS: Takeda lifts outlook, eyes return to sustainable growthLSE:0RN3Takeda Pharmaceutical Co Ltd
24/09/202409h49Alliance NewsAlliance NewsTakeda Pharmaceutical says Fruzaqla cancer drug gets Japan backingLSE:0RN3Takeda Pharmaceutical Co Ltd
24/06/202411h00Alliance NewsAlliance NewsIN BRIEF: Hutchmed China notes Takeda obtains EU approval for FruzaqlaLSE:0RN3Takeda Pharmaceutical Co Ltd
09/05/202410h36Alliance NewsAlliance NewsTOP NEWS: Takeda Pharmaceutical profit sinks as expenses mountLSE:0RN3Takeda Pharmaceutical Co Ltd
22/04/202421h41Alliance NewsAlliance NewsTakeda, Astellas and Sumitomo to create new drug discovery companyLSE:0RN3Takeda Pharmaceutical Co Ltd
27/03/202413h56PR Newswire (US)Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAELSE:0RN3Takeda Pharmaceutical Co Ltd
09/11/202313h16Alliance NewsAlliance NewsHutchmed hails Takeda's fruquintinib approval from US for cancer formLSE:0RN3Takeda Pharmaceutical Co Ltd
30/10/202313h24Alliance NewsAlliance NewsTakeda Pharmaceutical first half profit falls as costs outpace revenueLSE:0RN3Takeda Pharmaceutical Co Ltd
29/09/202311h12Alliance NewsAlliance NewsHutchmed notes Takeda submits fruquintinib drug application in JapanLSE:0RN3Takeda Pharmaceutical Co Ltd
22/09/202316h15PR Newswire (US)Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and OlderLSE:0RN3Takeda Pharmaceutical Co Ltd
27/07/202311h26Alliance NewsAlliance NewsTakeda keeps guidance unchanged despite drop in quarterly profitLSE:0RN3Takeda Pharmaceutical Co Ltd
12/07/202314h22Alliance NewsAlliance NewsJapan's Takeda pulls dengue vaccine candidate in USLSE:0RN3Takeda Pharmaceutical Co Ltd
16/06/202309h51Alliance NewsAlliance NewsHutchmed, Takeda Fresco-2 study published in The LancetLSE:0RN3Takeda Pharmaceutical Co Ltd
11/05/202312h51Alliance NewsAlliance NewsTOP NEWS: Takeda outlook downbeat as Covid wanes, hit from genericsLSE:0RN3Takeda Pharmaceutical Co Ltd
02/02/202311h57Alliance NewsAlliance NewsTakeda Pharmaceutical set for annual guidance as 9-month results upLSE:0RN3Takeda Pharmaceutical Co Ltd
08/12/202217h49Alliance NewsAlliance NewsTakeda Pharmaceutical gets EC approval for dengue vaccineLSE:0RN3Takeda Pharmaceutical Co Ltd
23/11/202213h49Alliance NewsAlliance NewsIN BRIEF: USD FDA accepts Takeda's TAK-003 for priority reviewLSE:0RN3Takeda Pharmaceutical Co Ltd
28/07/202218h10Alliance NewsAlliance NewsTakeda first quarter profit drops despite revenue increaseLSE:0RN3Takeda Pharmaceutical Co Ltd
11/05/202214h23Alliance NewsAlliance NewsTakeda annual profit drops on investment losses but revenue climbsLSE:0RN3Takeda Pharmaceutical Co Ltd
19/04/202209h19Alliance NewsAlliance NewsTakeda's Nuvaxovid vaccine approved for use in JapanLSE:0RN3Takeda Pharmaceutical Co Ltd
07/09/202107h10Alliance NewsAlliance NewsTakeda inks deal with Japan's government to supply Novavax vaccinesLSE:0RN3Takeda Pharmaceutical Co Ltd
09/06/202118h22PR Newswire (US)Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient communityLSE:0RN3Takeda Pharmaceutical Co Ltd
11/05/202109h30Alliance NewsAlliance NewsTOP NEWS: Takeda Pharmaceutical profit surges; guides boosted revenueLSE:0RN3Takeda Pharmaceutical Co Ltd
29/10/202008h41Alliance NewsAlliance NewsTOP NEWS: Takeda Pharmaceutical Ups Guidance As Profit Rises In HalfLSE:0RN3Takeda Pharmaceutical Co Ltd
07/08/202012h25Alliance NewsAlliance NewsNovavax Turns To Takeda To Manufacture Covid-19 Vaccine In JapanLSE:0RN3Takeda Pharmaceutical Co Ltd
03/08/202012h35Alliance NewsAlliance NewsGLOBAL TRADING UPDATE SUMMARY: Murata's First-Quarter Profit Drops 15%LSE:0RN3Takeda Pharmaceutical Co Ltd
31/07/202012h04Alliance NewsAlliance NewsTOP NEWS: Takeda Profit More Than Triples In Quarter; Ups GuidanceLSE:0RN3Takeda Pharmaceutical Co Ltd
29/06/202011h06Alliance NewsAlliance NewsTakeda Earnings To Be Hurt By Novartis Pulling Xiidra ApplicationLSE:0RN3Takeda Pharmaceutical Co Ltd
22/06/202011h10Alliance NewsAlliance NewsTakeda Pharmaceutical To Get USD564 Million One-Off Profit BoostLSE:0RN3Takeda Pharmaceutical Co Ltd
 Showing the most relevant articles for your search:LSE:0RN3

Dernières Valeurs Consultées

BIT
P1SE89
BNP Paribas Issuance
NASDAQ
LSCC
Lattice Semiconductor
AQSE
GDWN.GB
Goodwin
BIT
W0J3M7
UBS
TG
SQ3
Block
DBI
I1P6
Xtr MSCI Korea UCITS ETF...
BIT
F39639
Vontobel Financial Produ...
AQSE
FILE
File Forge Technology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés

BLACK FRIDAY

ADVFN

Célébrons nos 25 ans Est 1999-2024

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Cours Euronext en temps réel et illimités sur le site. Carnet d'ordres Euronext en direct